NCT05387941View on ClinicalTrials.gov

Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 14, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2028

Conditions
Retinopathy of Prematurity
Interventions
DRUG

Dexamethasone Ophthalmic

one drop daily in each eye with retinopathy of prematurity of a predefined stage.

Trial Locations (2)

22185

RECRUITING

Skåne University Hospital, Lund

41685

RECRUITING

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
lead

Region Skane

OTHER